ReviewHuman genomics2025
Data visiting governance: a conceptual framework.
Review in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Management discussion of laws and regulations on human genetic resources in China: a scoping review.BMC medical ethics · 2026Article
- Federated, governed, and interoperable? The emerging architecture of public human genomic data infrastructures: a European perspective.Frontiers in genetics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As genomic research scales globally, legal constraints such as data localization provisions in data privacy and other laws and ethical imperatives around privacy and sovereignty increasingly challenge traditional models of data sharing. Data visiting, where analysis occurs within the provider's computing environment without moving the data, offers a promising alternative, yet its governance remains underdeveloped. This article introduces the Seven-Dimensional Data Visiting Framework (7D-DVF), a structured tool for designing, assessing, and regulating data visiting systems in genomics. Building on the Global Alliance for Genomics and Health (GA4GH) data sharing lexicon, the framework disaggregates data visiting into seven adjustable dimensions: researcher autonomy, data location, data visibility, nature of the shared data, output governance, trust and control model, and auditability and traceability. Each dimension operates as a governance lever, enabling proportional, context-sensitive configurations that balance privacy, utility, and legal compliance. The article illustrates how the 7D-DVF can guide practical implementation through checklists and real-world scenarios, including institutional data control, Indigenous data sovereignty, and federated AI model training. By shifting genomic governance from reactive compliance to design-based stewardship, the 7D-DVF equips stakeholders to operationalize secure, lawful, and future-ready data sharing practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.